Aesthetic Medical International Hldngs Group Ltd Sponsored ADR

PAIYY Healthcare Medical Care Facilities

In the quarter to June 2025, revenue grew 25,427.4% and EPS grew 76.8%, each against the same quarter a year earlier.

0.01 0.00 0.00%
Market cap
$15.9M
P/E
0.0×
Fwd P/E
8.3×
Dividend yield
—
F-score
5/9
Altman Z
n/a
Beneish M
−2.30
Dividend safety
12/100
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Piotroski F-Score
5 5 5 5 2 1 — — — —
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 17.35 13.37 13.37 13.37
P/S ratio
0.05 0.13 0.32 0.38 0.50 0.88 0.00 0.00 0.00 0.00
P/FCF ratio
0.00 0.00 0.00 0.00 15.61 9.95 5.64 0.00 0.00 0.00
Beneish M-Score
(2.30) (3.56) (3.39) (2.48) (9.56) (3.29) (2.58) — — —
P/Operating CF
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/B ratio
31.46 10.59 6.54 0.00 5.16 1.86 1.16 0.00 0.00 0.00
Dividend Safety Score
12 — — — — — — — — —
Price to Tangible BV
0.00 0.00 0.00 0.00 12.96 3.64 1.71 0.00 0.00 0.00
EV/Sales
0.09 0.21 0.40 0.66 0.68 1.09 0.00 0.00 0.00 0.00
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Operating CF
(6.87) (10.71) (15.77) (29.00) 21.08 12.37 7.31 0.00 0.00 0.00
EV/FCF
(0.57) (0.89) (1.31) (2.41) 21.08 12.37 7.31 0.00 0.00 0.00
Quick Ratio
0.27 0.18 0.23 0.09 0.15 0.57 0.90 1.50 1.12 —
Current Ratio
0.31 0.22 0.27 0.14 0.21 0.68 1.00 1.65 1.71 —
Net Debt/EBITDA
1.81 0.68 1.68 12.06 (0.98) (2.21) (0.16) 0.67 4.03 0.00
Debt/Assets
28.24% 17.67% 18.79% 36.95% 47.12% 23.69% 13.41% 24.77% 0.00% —
Debt/Equity
(3.34) 9.20 3.13 (1.60) (1.46) 0.58 0.24 (0.67) (10.37) —
Asset Turnover
1.45 1.43 1.20 1.17 0.83 0.87 0.99 2.25 1.10 0.00
Operating CF/Net income
0.23 (3.99) (1.98) 0.99 (0.09) 0.00 0.64 (0.12) (0.93) 0.98
Capex/Depreciation
(0.01) (0.47) (0.84) (0.03) (0.34) (0.42) (0.91) (2.42) 0.00 0.00
Interest Coverage
(1.75) (0.50) (2.78) (2.12) (12.33) (6.63) 0.13 7.19 18.86 9.00
ROE
314.85% (91.69%) 75.81% 47.61% (554.53%) (46.38%) 82.56% 170.03% 47.52% 0.00%
ROA
(10.70%) (3.78%) (6.59%) (13.28%) (75.82%) (22.60%) 15.55% (74.64%) (12.11%) 0.00%
ROIC
(42.40%) (16.40%) (44.68%) (67.90%) (491.74%) (22.62%) (2.33%) 0.00% 0.00% —
Return on Tangible Assets
364.52% 41.79% (849.11%) 52.43% 847.75% (53.96%) 26.28% (72.82%) (24.26%) 0.00%
Average Days of Receivables
25.37 14.17 17.99 19.04 24.79 48.47 35.32 74.60 24.27 0.00
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
45.52% 45.24% 54.33% 56.24% 94.74% 82.22% 70.12% 58.98% 56.30% 60.36%
Intangible Assets out of Total Assets
0.06 0.08 0.07 0.07 0.06 0.20 0.17 0.10 0.00 —
Share Based Compensation of Revenue
0.00% 0.00% 1.10% 4.11% 5.49% 8.76% 5.50% 0.00% 0.00% 0.00%
Graham Net Nets
(6.60) (3.81) (1.98) (2.33) (0.80) (0.51) (0.30) (0.75) (0.75) (0.75)
Graham Number
— 0.00 0.00 2.51 9.44 0.00 0.00 0.00 0.00 0.00
Earnings Yield
(69.53%) (68.16%) (63.11%) (29.51%) (69.83%) (29.60%) 5.76% 7.48% 7.48% 7.48%
Free Cash Flow Yield
(333.00%) (182.61%) (95.18%) (72.04%) 6.41% 10.05% 17.73% 0.00% 0.00% 0.00%
Revenue per Share
2.10 2.20 2.20 3.65 4.55 6.00 8.18 8.40 4.30 3.67
Operating CF per Share
(0.04) 0.23 0.24 (0.41) 0.36 (0.01) 0.82 0.33 0.44 0.31
Capex per Share
0.00 (0.09) (0.18) (0.01) (0.23) (0.30) (0.72) (0.86) 0.00 0.00
Free Cash Flow per Share
(0.04) 0.14 0.06 (0.42) 0.13 (0.31) 0.10 (0.53) 0.44 0.31
Cash per Share
0.19 0.13 0.20 0.07 0.28 0.35 1.45 1.12 0.67 0.00
Shareholders Equity per Share
(0.13) 0.03 0.11 (0.69) (1.31) 2.83 5.56 (2.75) (0.30) 0.00
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
(0.13) 0.03 0.11 (0.69) (1.31) 2.83 5.56 (2.75) (0.30) 0.00
Free Cash Flow
(1.76) 6.81 2.66 (11.41) 2.76 (6.66) 1.56 (7.22) 10.55 7.45
Working Capital
(40.92) (43.67) (42.36) (69.28) (66.33) (13.84) (0.09) 16.87 14.47 —
Capital Expenditures
(0.06) (4.27) (7.83) (0.25) (5.16) (6.54) (11.00) (11.74) (7.05) (5.90)
Net Current Asset Value
(58.38) (54.08) (58.71) (88.37) (100.70) (58.86) (27.76) (97.15) (57.21) —
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales
0.00 0.04 0.08 0.00 0.05 0.05 0.09 0.10 0.00 0.00
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.21 0.25 0.22 0.19 0.28 0.20 0.16 0.14 0.13 0.00
Cash ROIC
(7.60%) 35.18% 9.36% (85.62%) 14.28% (6.35%) 1.22% (237.48%) 12.61% 0.00%
Accounts Receivable Turnover
18.17 23.80 19.39 16.61 8.29 8.85 7.05 7.58 12.51 0.00
Accounts Payable Turnover
9.35 9.14 7.87 7.93 11.99 14.09 17.24 16.45 21.94 20.69
Inventory Turnover
23.06 27.19 16.07 10.53 12.19 12.01 11.45 11.10 18.13 17.09
Average Days of Payables
32.64 42.25 42.93 54.26 30.33 34.43 22.51 20.27 27.15 6.49
Days of Inventory on Hand
17.66 13.02 15.77 32.33 29.66 34.10 34.55 29.85 40.45 (0.19)
Average Receivables
5.53 4.42 4.97 6.00 12.07 14.76 17.84 15.19 8.25 —
Average Payables
5.78 6.36 6.47 5.90 4.86 3.67 2.32 2.38 1.58 1.58
Average Inventory
2.34 2.14 3.17 4.44 4.78 4.31 3.49 3.52 1.91 1.91
Average Assets
69.35 73.43 80.21 85.31 119.92 150.97 126.87 51.11 93.65 —
Average Common Equity
(2.36) 3.03 (6.98) (23.80) 16.40 73.57 23.89 (22.44) (23.87) —

Fold the line items

Columns are period end dates